Lawmakers yesterday questioned the legality of an online platform set up by the government to recruit participants for COVID-19 vaccine clinical trials.
The Central Epidemic Command Center (CECC) launched the online platform on Wednesday last week, and said people can sign up until Nov. 30.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said at the time that three domestic manufacturers that are developing COVID-19 vaccine candidates would soon complete phase 1 clinical trials and as phase 2 vaccine trials would need more participants, the CECC launched the platform to help shorten the recruitment process and speed up the trials.
Photo: CNA
As of yesterday, more than 19,000 people had registered, close to the center’s target of 20,000.
At a meeting of the legislature’s Social Welfare and Environmental Hygiene Committee yesterday, Chinese Nationalist Party (KMT) Legislator Chiang Wan-an (蔣萬安) said that the online registration could be illegal, as it does not provide warnings in accordance with regulations on clinical trial recruitment for volunteers, the advert has not received approval from the Institutional Review Board and it likely breached other regulations.
“The trial advert must not have provisions stating that participants will receive free medical treatment or a financial subsidy, or that it is available for a limited time only to push people to sign up before the deadline,” Chiang said.
“It must not contain words, graphics, photos or illustrations to entice or force people into signing up,” he added.
In the past, the ministry would issue regulations warning people about the risks associated with clinical trials, “but now [the trials] were publicized through a press conference, which was also circulated through online platforms such as Line, Facebook and others, and only presented the potentially good points. We did not see any warnings about possible side effects and associated risks,” he added.
“The government has set a bad example, skirting around possible illegalities. In the future, can pharmaceutical firms and companies making medical vaccines do the same? That is, they can first publicize on an online platform to collect the personal data of volunteers, then claim it was not an open call for participants,” Chiang said.
Democratic Progressive Party Legislator Lin Shu-fen (林淑芬) also questioned the program.
“The trials would involve more than 20,000 people, but if something goes wrong, can the victims receive compensation, and what if the vaccine company cannot pay?” she asked. “Our government led the way in publicizing the trials, but not in shouldering the responsibility for compensation. Is this proper?”
Deputy Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) clarified that it was only a platform for registration, and not an official recruitment for clinical trial participants.
“The platform is a means for people to register, and asking them if they are willing to take part in the clinical trials, to provide their personal information. When the trial program is approved, then the official recruitment can start, and the vaccine company can select suitable volunteers,” Hsueh said.
As to whether the advert conforms to the law, it will have to be judged on a case-by-case basis, he added.
The Ministry of Education (MOE) is to launch a new program to encourage international students to stay in Taiwan and explore job opportunities here after graduation, Deputy Minister of Education Yeh Ping-cheng (葉丙成) said on Friday. The government would provide full scholarships for international students to further their studies for two years in Taiwan, so those who want to pursue a master’s degree can consider applying for the program, he said. The fields included are science, technology, engineering, mathematics, semiconductors and finance, Yeh added. The program, called “Intense 2+2,” would also assist international students who completed the two years of further studies in
Former president Tsai Ing-wen (蔡英文) departed for Europe on Friday night, with planned stops in Lithuania and Denmark. Tsai arrived at Taiwan Taoyuan International Airport on Friday night, but did not speak to reporters before departing. Tsai wrote on social media later that the purpose of the trip was to reaffirm the commitment of Taiwanese to working with democratic allies to promote regional security and stability, upholding freedom and democracy, and defending their homeland. She also expressed hope that through joint efforts, Taiwan and Europe would continue to be partners building up economic resilience on the global stage. The former president was to first
Taiwan will now have four additional national holidays after the Legislative Yuan passed an amendment today, which also made Labor Day a national holiday for all sectors. The Chinese Nationalist Party (KMT) and Taiwan People’s Party (TPP) used their majority in the Legislative Yuan to pass the amendment to the Act on Implementing Memorial Days and State Holidays (紀念日及節日實施辦法), which the parties jointly proposed, in its third and final reading today. The legislature passed the bill to amend the act, which is currently enforced administratively, raising it to the legal level. The new legislation recognizes Confucius’ birthday on Sept. 28, the
MORE NEEDED: Recall drives against legislators in Miaoli’s two districts and Hsinchu’s second district were still a few thousand signatures short of the second-stage threshold Campaigners aiming to recall Chinese Nationalist Party (KMT) legislators yesterday said they expect success in 30 out of 35 districts where drives have passed the second-stage threshold, which would mark a record number of recall votes held at once. Hsinchu County recall campaigners yesterday announced that they reached the second-stage threshold in the recall effort against Legislator Lin Szu-ming (林思銘). A total of 26,414 signatures have been gathered over the past two months, surpassing the 10 percent threshold of 23,287 in Hsinchu County’s second electoral district, chief campaigner Hsieh Ting-ting (謝婷婷) said. “Our target is to gather an additional 1,500 signatures to reach